PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30112114-1	2018	Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR.	Sorafenib	26-35	AKT serine/threonine kinase 1	Homo sapiens	70-73	
30112114-9	2018	The combination of sorafenib with targeted therapies exhibited synergistic anti-HCC biological activity concomitantly with highly effective inhibition of MAPK and AKT/mTOR signaling.	Sorafenib	19-28	AKT serine/threonine kinase 1	Homo sapiens	163-166